This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most sub-disciplines of radiation oncology.

This session reviews current evidence based guidelines as well as the basis for guidelines pertaining to the treatment of esophageal and gastric cancer. Worldwide changes in epidemiology will be discussed. Current treatment strategies will be reviewed and compared.

The eContouring for Gastrointestinal Cancer Case Library contains 1 case, case vingette, and reference documents from cases from the 2017 ASTRO Annual Meeting.

A number of recent studies have advanced knowledge about the treatment of gastrointestinal cancers. Converging evidence suggests that novel aspects of treatment such as radiation therapy boosts, chemoradiation vs.

This session will review current evidence based guidelines as well as the basis for guidelines pertaining to the treatment of esophageal and gastric cancer. Worldwide changes in epidemiology will be discussed. Current treatment strategies will be reviewed and compared.

IJROBP Journal SA-CME activity for April 1, 2018 (Volume 100, Issue 5) provides practitioners with the  knowledge to make competent recommendations when they meet patients with borderline resectable pancreatic cancer.

IJROBP Journal SA-CME activity for March 15, 2018 (Volume 100, Issue 4) reviews the data available for treating rectal cancer in elderly patients, their ability to tolerate treatment and available options for achieving the correct balance between therapeutic opportunity and therapeutic b

This activity on Gastrointestinal Cancer will provide a review of the most highly rated abstracts in the GI track from the ASTRO 2017 Annual Meeting. This activity will highlight results of technological advances and clinical research that will provide the attendees with knowledge to manage patie

IJROBP Journal SA-CME activity for February 1, 2018 (Volume 100, Issue 2) provides practitioners with the knowledge needed to discuss treatment effects on non tumor liver (“normal” liver) in patients treated for hepatocellular cancer.

The first session will provide a clinical update on the optimal management of upper GI malignancies including esophageal cancer, gastric cancer and pancreatic cancer.